Article
HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa.
PloS one - 1 Jan 2026
Tchiakpe Edmond, Keke René Kpemahouton, Recordon-Pinson Patricia, Diouara Abou Abdallah Malick, Andreola Marie-Line, Bachabi Moussa, Afangnihoun Aldric, Gbaguidi Eric, Osawe Sophia, Issiaka Maiga Almoustapha, Diop-Ndiaye Halimatou, Touré-Kane Coumba, Yessoufou Akadiri
Abstract excerpt
Benin adopted the World Health Organization's (WHO) "Test and Treat" recommendation in 2016 and, since 2019, has updated this protocol by including dolutegravir (DTG) as the preferred first-line treatment. Study aimed to assess the prevalence of virological failure (VL > 3log copies/mL) and review genetic diversity and antiretroviral resistance mutations in patients on antiretroviral treatment for at least 12...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
